A naturalistic evaluation of intramuscular ziprasidone versus intramuscular olanzapine for the management of acute agitation and aggression in children and adolescents

Journal of Child and Adolescent Psychopharmacology

Volumn 16, Issue 6, 2006, Pages 671-677

  Khan, Shamima S ^a,c   Mican, Lisa M ^b  

^a Austin State Hospital   (United States)

^b UNIVERSITY OF TEXAS AT AUSTIN   (United States)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHISTAMINIC AGENT; LORAZEPAM; OLANZAPINE; ZIPRASIDONE;

ACUTE DISEASE; ADOLESCENT; AGGRESSION; AGITATION; CHILD PSYCHIATRY; COMPARATIVE STUDY; DEMOGRAPHY; DOCUMENTATION; DRUG EFFICACY; DRUG SAFETY; EMERGENCY TREATMENT; ETHNICITY; FEMALE; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; INFORMATION PROCESSING; JOINT STIFFNESS; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MENTAL DISEASE; NATURALISTIC INQUIRY; NAUSEA; OUTCOME ASSESSMENT; PARKINSONISM; PATIENT CARE; PRURITUS; PSEUDOPARKINSONISM; RETROSPECTIVE STUDY; REVIEW; SEDATION; SEX DIFFERENCE; SIDE EFFECT; SOMNOLENCE; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME;

EID: 33846649511     PISSN: 10445463     EISSN: None     Source Type: Journal    
DOI: 10.1089/cap.2006.16.671     Document Type: Review

References (12)

1. Allen MH, Currie GW, Carpenter D, Ross RW, Dorherty JP: Treatment of behavioral emergencies 2005. J Psychiatr Pract 11(Suppl 1):5-108, 2005.
2. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, 4th edition, text revision (DSM-IV-TR). Washington, DC, American Psychiatric Association, 2000.
3. Brook S, Lucey JV, Gunn KP: Intramuscular ziprasidone compared with intramuscular haloperidol in the treatment of acute psychosis. Ziprasidone I.M. Study Group. J Clin Psychiatry 61:933-941, 2000.
4. Daniel DG, Potkin SG, Reeves KR, Swift RH, Harrigan EP: Intramuscular (IM) ziprasidone 20 mg is effective in reducing acute agitation associated with psychosis: a double-blind, randomized trial. Psychopharmacology 155:128-134, 2001.
5. Lesem MD, Zajecka JM, Swift RH, Reeves KR, Harrigan EP: Intramuscular Ziprasidone, 2 mg versus 10 mg, in the short-term management of agitated psychotic patients. J Clin Psychiatry 62:12-18, 2001.
6. Meehan K, Zhang F, David S, Tohen M, Janicak P, Small J, Koch M, Rizk R, Walker D, Tran P, Breier A: A double-blind, randomized comparison of the efficacy and safety of intramuscular injections of olanzapine, lorazepam, or placebo in treating acutely agitated patients diagnosed with bipolar mania. J Clin Psychopharmacol 21:389-397, 2001.
7. nd, Keiner S, Van Orden K, Sverd J, Sardana S, Woodlock D, Schweitzer R, Rube D: "Real World" atypical antipsychotic prescribing practices in public child and adolescent inpatient setting. Schizophr Bull 28:111-121, 2002.
8. Pappadopulos E, MacIntyre JC II, Crismon ML, Findling RL, Malone RP, Derivan A, Schooler N, Sikich L, Greenhill L, Schur SB, Felton CJ, Kranzler H, Rub DM, Sverd J, Finnerty M, Keiner S, Siennick SE, Jensen PS: Treatment recommendations for the use of antipsychotics for aggressive youth (TRAAY). Part II. J Am Acad Child Adolesc Psychiatry 42:145-161, 2003.
9. Potenza MN, Holmes JP, Kanes SJ, McDougle CJ: Olanzapine treatment of children, adolescents, and adults with pervasive developmental disorders: An open-label pilot study. J Clin Psychopharmacol 19:37-44, 1999.
10. Product Information: Zyprexa® olanzapine tablets, Zyprexa® Zydis® Orally Disintegrating Tablets, Zyprexa® IntraMuscular, olanzapine for Injection. Eli Lilly and Company, Indianapolis, IN. Literature revised May 26, 2005.
11. Schur SB, Sikich L, Findling RL, Malone RP, Crismon ML, Derivan A, MacIntyre II JC, Pappadopulos E, Greenhill L, Schooler N, Van Ordern K, Jensen PS: Treatment recommendations for the use of antipsychotics for aggressive youth (TRAAY). Part I: A review. J Am Acad Child Adolesc Psychiatry 42:132-144, 2003.
12. Wright P, Birkett M, David SR, Meehan K, Ferchland I, Alaka KJ, Saunders JC, Krueger J, Bradley P, San L, Bernardo M, Reinstein M, Breier A: Double-blind, placebo-controlled comparison of intramuscular olanzapine and intramuscular haloperidol in the treatment of acute agitation in schizophrenia. Am J Psychiatry 158:1149-1151, 2001.